Clinical Trial Update: Safety and Durability of Sirolimus for Treatment of LAM

View source ↗

Summary

This clinical trial update reports ongoing safety and durability evaluation of sirolimus for lymphangioleiomyomatosis with recruitment continuing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphangioleiomyomatosis

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: University of Cincinnati | Conditions: Lymphangioleiomyomatosis | Status: RECRUITING